Contract facts
SBANo full NAICS 541380 intel page yet. Browse NAICS intelligence
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS is a federal SBA award for Army Med Res Acq Activity held by Eitr Biologics, Inc. Estimated value $1.5M ($730K obligated). Current period of performance ends Dec 10, 2025 (potential Dec 10, 2026). Last award drew 2 bidders. Place of performance: SAN DIEGO CA. Related solicitation HT942523Q0059.
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
Recompete timing
PublicCurrent PoP ended Dec 10, 2025 (254 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordEitr Biologics, Inc — $37.9M obligated across 9 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942524P0015?
HT942524P0015 (Sorting peripheral BLOOD mononuclear CELLS FROM) is a Army Med Res Acq Activity award with a potential value of $1.5M, currently held by Eitr Biologics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-24-P-0015?
HT9425-24-P-0015 is the dashed form of PIID HT942524P0015 (Sorting peripheral BLOOD mononuclear CELLS FROM), held by Eitr Biologics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942524P0015?
Army Med Res Acq Activity awarded HT942524P0015 to Eitr Biologics, Inc (potential $1.5M).
Who is the incumbent on HT942524P0015?
Eitr Biologics, Inc is the incumbent with $37.9M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Dec 10, 2025.
When does Eitr Biologics, Inc’s HT942524P0015 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 10, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.